Today: 9 April 2026
Dow Jones today: Record highs hold as investors brace for Friday jobs report
6 January 2026
2 mins read

Dow Jones today: Record highs hold as investors brace for Friday jobs report

New York, Jan 6, 2026, 13:32 EST — Regular session

  • Dow extends its record run in afternoon trade
  • UnitedHealth and Amazon help drive gains among blue-chip names
  • Traders focus turns to Friday’s U.S. jobs report and Fed signals

The Dow Jones Industrial Average rose about 0.9% on Tuesday and hovered near another record, while the SPDR Dow Jones Industrial Average ETF (DIA), which tracks the index, also gained about 0.9%. The S&P 500 and Nasdaq were up roughly 0.5% each. Investing.com

The move keeps the blue-chip index within sight of the 50,000 mark after a strong start to 2026. Investors positioned for Friday’s nonfarm payrolls report — the government’s monthly jobs count — for clues on how soon the Federal Reserve may cut rates again, with healthcare and technology shares providing support, Art Hogan, chief market strategist at B. Riley Wealth, said. Reuters

Richmond Fed President Thomas Barkin struck a cautious tone on Tuesday, saying future rate changes will need to be “finely tuned” to incoming data as officials balance risks to both inflation and employment. The Fed’s next policy meeting is set for Jan. 27-28, and Barkin said the December jobs report due Friday would help fill an information gap after disruptions to some federal data releases. Reuters

Inside the Dow, UnitedHealth and Amazon led much of the benchmark’s climb, reflecting how a handful of big movers can swing the index. The Dow is price-weighted — meaning higher-priced stocks carry more influence — and a $1 move in any component translates into about 6 points on the index. MarketWatch

Elsewhere, the market’s AI-linked trade showed sharp cross-currents. Johnson Controls and Trane Technologies slid after Nvidia CEO Jensen Huang said the chipmaker’s next platform could reduce cooling needs in data centers; Barclays analyst Julian Mitchell warned investors not to brush off Nvidia’s comments, even if they seemed dramatic. Reuters

The CES technology show in Las Vegas stayed in focus after Advanced Micro Devices CEO Lisa Su showcased new AI chips and OpenAI President Greg Brockman underscored how much chip advances matter to the company’s computing needs. AMD also detailed a next-generation processor line it expects to launch in 2027. Reuters

Financials were mixed after a high-profile executive shift. AIG fell after it named Aon’s Eric Andersen as its next CEO and said Peter Zaffino will move to an executive chair role; KBW called Andersen a “highly-respected” insurance leader, while J.P. Morgan said the change injects uncertainty into the investment case. Reuters

Tuesday’s gains built on Monday’s surge that pushed the Dow to a record close, with the index up 1.23% to 48,977.18 as banks and energy stocks rallied. The jump followed a U.S. military strike that captured Venezuelan President Nicolas Maduro, with U.S. Bank’s Rob Haworth pointing to expectations for more investment tied to Venezuela and Interactive Brokers’ Steve Sosnick citing a shift toward financial stocks as investors look beyond tech. Reuters

But the rally still leans on two big assumptions: that the Fed can ease policy without reigniting inflation and that geopolitics does not spill into broader risk aversion. Traders have been pricing in two rate cuts this year, while questions remain over how fast and at what cost companies could bring Venezuelan crude back to market, Siebert Financial’s Mark Malek said. Reuters

Next up, investors will parse a run of labor-market updates ahead of Friday’s nonfarm payrolls report on Jan. 9. Markets are also watching for planned talks this week between the Trump administration and oil company executives on Venezuelan production after Monday’s energy-led spike. wtvbam.com

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
KLA (KLAC) stock rises after Cantor upgrade as CES AI headlines keep chip tools in focus
Previous Story

KLA (KLAC) stock rises after Cantor upgrade as CES AI headlines keep chip tools in focus

Guardant Health stock jumps 7% as Evercore downgrades — what investors watch next
Next Story

Guardant Health stock jumps 7% as Evercore downgrades — what investors watch next

Go toTop